Daily Archives: September 4, 2020
Image: SARS-CoV-2 infection of airway cells
4 Sep, 2020 | 02:15h | UTCImages in Clinical Medicine: SARS-CoV-2 Infection of Airway Cells – New England Journal of Medicine
Editorial: Are we underestimating seroprevalence of SARS-CoV-2?
4 Sep, 2020 | 02:17h | UTCAre we underestimating seroprevalence of SARS-CoV-2? – The BMJ
Commentary: Are antibody tests underestimating the spread of COVID-19? – St. George’s University of London
Review: Coagulopathy of Covid-19
4 Sep, 2020 | 02:14h | UTCCoagulopathy of Coronavirus Disease 2019 – Critical Care Medicine
Commentary on Twitter
What you need to know about #Covid19 #coagulopathy is all in one place – @CCM. This will help target your anticoagulation plans for COVID care. @SCCM https://t.co/gKUbc995ra
— Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FAAN, FCCM (@SCCMPresident) September 1, 2020
Editorial: Reopening schools during COVID-19
4 Sep, 2020 | 02:16h | UTCReopening schools during COVID-19 – Science
Evolution and epidemic spread of SARS-CoV-2 in Brazil
4 Sep, 2020 | 02:11h | UTCEvolution and epidemic spread of SARS-CoV-2 in Brazil – Science
[Preprint] Diarrhea and vomiting may be a key sign of Covid-19 in children
4 Sep, 2020 | 02:12h | UTCDiarrhoea and vomiting may be key sign of Covid in children – The Guardian
Original Study: Seroprevalence of SARS-CoV-2 antibodies in children – A prospective multicentre cohort study – medRxiv
Commentary on Twitter
(1/10) Important pre-print study (interpret cautiously) of 992 UK children showing 6.9% had #SARSCoV2 antibodies, suggesting they are at similar risk of infection as adults, & that young and older children are similarly susceptible. 50% were asymptomatic.https://t.co/sUgvIlnmE0 pic.twitter.com/nxeHkAODLF
— Dr Zoë Hyde (@DrZoeHyde) September 3, 2020
Case report: Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection
4 Sep, 2020 | 02:10h | UTCCommentary: Can COVID-19 cause diabetes? – MedicalXpress
Commentary on Twitter
https://twitter.com/nresearchnews/status/1301179637704331265
COVID-19 and mRNA vaccines—first large test for a new approach
4 Sep, 2020 | 02:08h | UTCCOVID-19 and mRNA Vaccines—First Large Test for a New Approach – JAMA
Forty postmortem examinations in COVID-19 Patients: Two distinct pathologic phenotypes and correlation with clinical and radiologic findings
4 Sep, 2020 | 02:05h | UTC
Commentary on Twitter
Our COVID autopsy study is now online! We describe 2 distinct pathologic phenotypes and correlate with clinical and radiologic data. So proud of this team! 💕@ColumbiaPath @AJCPjournal #pulmpath #pathology #autopsy #NYC #COVID19 #covid https://t.co/f3xhc0v1si
— Simona De Michele, MD (@SDeMicheleMD) September 3, 2020
Opinion: Herd immunity is not a strategy
4 Sep, 2020 | 02:09h | UTCHerd Immunity Is Not a Strategy – The Atlantic
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
4 Sep, 2020 | 02:06h | UTC
Malignant pleural effusions: New evidence on management
4 Sep, 2020 | 02:03h | UTCMalignant pleural effusions (MPE): new evidence on management – Evidently Cochrane
Original Review: Interventions for the management of malignant pleural effusions: a network meta‐analysis – Cochrane Library
Incidence of malformations after early pregnancy exposure to Modafinil
4 Sep, 2020 | 02:02h | UTCIncidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway – JAMA (free for a limited period)
Commentary: Narcolepsy drug did not increase risk of fetal malformation – Karolinska Institutet
Commentary on Twitter
Cohort study: Modafinil use during early pregnancy was not significantly associated with increased risk of major malformations (unexposed group = 2.1% vs. exposed = 2.6%; crude RR = 1.06; 0.35-3.26). 1st trimester only: RR = 0.44; 0.06-3.10 https://t.co/u4WsK2v31C
— P𝘧OL (@psychopharmacol) September 2, 2020